

** Drugmaker Shire's shares down 1.1 pct, underperforming the FTSE 100, after JP Morgan cuts PT on co to 5300p from 6100p ** Stoxx 600 Healthcare Inde...


(ShareCast News) - With Shire shares almost £20 short of last year's all-time high, the drug developer's chairwoman, chief executive and a clutch of s...


(Adds share price) LONDON, Feb 11 (Reuters) - Shire, the London-listed drugmaker buying Baxalta International for $32 billion, reported a better-than-...